CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THE AGREEMENT BECAUSE SUCH INFORMATION (I) IS CONSIDERED NOT MATERIAL TO INVESTORS AND (II) IS INFORMATION THAT THE REGISTRANT, CANOPY GROWTH CORPORATION., TYPICALLY TREATS AS PRIVATE OR CONFIDENTIAL IN THE...Credit Agreement • July 14th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • New York
Contract Type FiledJuly 14th, 2023 Company Industry JurisdictionCREDIT AGREEMENT, dated as of March 18, 2021 (this “Agreement”), among CANOPY GROWTH CORPORATION, a corporation incorporated under the federal laws of Canada (the “Parent Borrower”), 11065220 Canada Inc., a corporation incorporated under the federal laws of Canada (the “Co-Borrower” and, together with the Parent Borrower, the “Borrowers” and each, a “Borrower”), the LENDERS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) and Collateral Agent (as defined below) for the Secured Parties (as defined below).
INDENTURE Made as of July 14, 2023 Between CANOPY GROWTH CORPORATION (the “Corporation”) and ODYSSEY TRUST COMPANY (the “Trustee”)Indenture • July 14th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledJuly 14th, 2023 Company Industry JurisdictionThe Corporation wishes to create and issue the Debentures (as herein defined) in the manner and subject to the terms and conditions of this Indenture; and
CANOPY GROWTH CORPORATION Redemption Agreement July 13, 2023Redemption Agreement • July 14th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • New York
Contract Type FiledJuly 14th, 2023 Company Industry Jurisdiction
VOTING SUPPORT AGREEMENTVoting Support Agreement • July 14th, 2023 • Canopy Growth Corp • Medicinal chemicals & botanical products • Ontario
Contract Type FiledJuly 14th, 2023 Company Industry JurisdictionWHEREAS each Securityholder is, as of the date of this Agreement, the registered and/or beneficial owner of that number of issued and outstanding common shares in the capital of the Corporation (collectively, the “Shares”) set forth in Schedule A.